组合疗法作为对抗口腔癌的有希望的方法
João P N Silva1, Bárbara Pinto1, Luís Monteiro1
1UNIPRO-Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences (IUCS), Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
组合疗法通过向微管和信号通路来改善口腔癌的结果. 本综述分析了当前的策略,强调了它们在克服耐药性和增强治疗反应方面的有效性.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 口腔癌是侵略性的,导致转移和高死亡率.
- 传统的治疗方法 (手术,化疗,辐射) 有显著的副作用.
- 组合疗法是局部晚期口腔癌的标准,改善了结果.
研究的目的:
- 为提供口腔癌综合疗法进展的深入分析.
- 探索当前的治疗选择和单一治疗的局限性.
- 要突出针对关键分子通路的组合方法.
主要方法:
- 对组合疗法的临床前和临床证据的审查.
- 对包括微管抑制剂和信号通路调节器在内的向药物的分析.
- 讨论组合策略的理由,有效性和挑战.
主要成果:
- 组合疗法显示治疗反应增强,克服药物耐药性.
- 准微管,DNA修复,EGFR,CDK,表观遗传阅读器和免疫检查点显示出有希望.
- 证据支持各种组合方法在临床前和临床环境中的有效性.
结论:
- 组合疗法对于改善口腔癌治疗结果至关重要.
- 解决毒性和个性化等挑战是临床翻译的关键.
- 未来的研究应该专注于优化口腔癌管理的组合策略.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
